InvestorsHub Logo
Followers 86
Posts 12714
Boards Moderated 0
Alias Born 10/12/2010

Re: biopharm post# 180731

Tuesday, 07/01/2014 2:03:19 AM

Tuesday, July 01, 2014 2:03:19 AM

Post# of 346043
Dmitry Gabrilovich : Peregrine Pharmaceuticals KOL :


Program 2014 Print

Each session begins with a 30 min keynote lecture and 15 min discussion with the invited senior experts. Then two young scientists will give a maximum 10 min presentation plus 5 min discussion. The closing lecture will be the BSRT Nikolaus Lecture which will be open for the general public.

Participants who present posters will give a 2 min speed talk explaining the main concepts or results of their projects.

Thursday Dec 4, 2014 : Session III:

Alice's Adventures in Wonderland: Which signals to follow to find the right way
Prof. Dmitry Gabrilovich (The Wistar Institute)
Young Scientist Presentations V-VI

https://www.bsrt-phdsymposium.de/index.php?option=com_content&task=view&id=221&Itemid=504

---------------------------------------------------------


Confirmed Keynote Speakers 2014

Prof. Frank Barry National University of Ireland
Prof. Fernando Carmago Boston Children's Hospital
Prof. Peter Friedl The University of Texas
Prof. Dmitry Gabrilovich The Wistar Institute
Prof. Nicholas Restifo National Cancer Institute
Prof. Ugur Sahin Universitätsmedizin Mainz
Prof. Seppo Vainio University of Oulu
Prof. Fiona Watt King's College London

https://www.bsrt-phdsymposium.de/index.php?option=com_content&task=view&id=228&Itemid=480

-----------------------------------------

"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline."
-- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News